巨菌衍生的7A胺通过整体蛋白β1/JNK/MSR1轴驱动动动脉硬化
Fengchan Li1, Haofu Ni1, Fan Tang1
1Cyrus Tang Medical Institute, Soochow University, Suzhou, 215123, China.
Frontiers of medicine
|December 16, 2025
概括
巨细胞塞马福林7A (SEMA7A) 通过促进通过整合素β1和MSR1.1吸收脂质来驱动动动动脉硬化. 抑制这种途径减少了小鼠的病变大小,为动脉样硬化提供了新的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
背景情况:
- 动脉样硬化涉及巨细胞泡细胞的形成,这是一个关键的病理过程.
- 赛马7A (SEMA7A) 是一种免疫调节分子,但其在动脉样硬化中的作用尚不清楚.
- 巨细胞衍生SEMA7A对动脉动脉生成的贡献需要进一步研究.
研究的目的:
- 为了研究巨细胞衍生SEMA7A在动脉样硬化中的作用.
- 阐明SEMA7A通过哪些分子机制影响动脉样硬化中的巨细胞功能.
- 评估针对动脉样硬化中的SEMA7A通路的治疗潜力.
主要方法:
- 对人类单核细胞基因表达数据 (GEO数据库) 的分析.
- 使用THP-1单细胞分化为巨细胞的体外研究.
- 在体内研究使用宏细胞特异性Sema7a淘汰性动脉样硬化小鼠模型.
- 使用GLPG0187.7.使用整合素β1的药理抑制.
主要成果:
- SEMA7A和整蛋白β1在巨细胞中高度表达,并在单细胞分化过程中升级.
- 宏细胞特异性的Sema7a删除显著减少了动脉样硬化病变的大小,并改善了斑块稳定性.
- 巨细胞SEMA7A通过整体蛋白β1/JNK信号传递促进MSR1表达和脂质吸收.
- 抑制整合素β1抑制了动脉样硬化进展.
结论:
- 巨细胞衍生的SEMA7A是动脉样硬化的一个关键驱动因素.
- 一个新的整合蛋白β1/JNK/MSR1轴调解SEMA7A的益动脉动脉效应.
- 向SEMA7A-整蛋白β1通路为动脉样硬化提供了一个有前途的治疗策略.
更多相关视频
09:57Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
Published on: August 12, 2019
10.1K
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
8.7K
相关概念视频
01:38Inflammation
61.4K
Overview
61.4K
01:30Atherosclerosis I: Introduction
795
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
795
01:17Intracellular Signaling Affects Focal Adhesions
3.4K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.4K
01:20The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
01:26Coronary Artery Disease II: Pathophysiology
340
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
340
01:16TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K